Proyectos de ley › 88.ª Asamblea General
Relating to insurance coverage for diagnostic breast cancer examinations, and including applicability provisions
Presentado por el comité Human Resources del Senado
Temas:Health care
La misma legislación: SSB 3162
Dónde está ahora
- Hecho: Presentado12 de febrero de 2020
- Hecho: Subcomité13 de febrero de 2020
- Hecho: Comité del Senado19 de febrero de 2020
- Se detuvo: Lo aprueba el SenadoMurió al terminar la Asamblea General
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2020 terminó el 14 de junio de 2020, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
La explicación oficial está en inglés; todavía no hay resumen en palabras sencillas.
This bill relates to insurance coverage for diagnostic breast cancer examinations. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses to provide coverage for diagnostic breast cancer examinations. “Diagnostic breast cancer examination” is defined in the bill as an examination of an abnormality, deemed medically necessary by a covered person’s health care professional, for the detection of breast cancer. The examination may be conducted using a diagnostic mammogram, breast magnetic resonance imaging, or breast ultrasound.
Lea la explicación completa
“Abnormality”, “diagnostic mammogram”, “breast magnetic resonance imaging”, and “breast ultrasound” are also defined in the bill. The policy, contract, or plan cannot require cost-sharing greater than the cost-sharing that the policy, contract, or plan requires for a screening mammogram. “Cost-sharing” and “screening mammogram” are defined in the bill. The bill applies to third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance is required to adopt rules to administer the requirements of the bill. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2021.
Senate subcommittee
Named February 13, 2020 (as SSB 3162). On February 18, 2020 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Nota fiscal
Cost: up to $129,000 Compare con otros proyectos
The fiscal impact of SF 2342 for shifting the share of costs associated with diagnostic breast cancer examinations from Plan members to the Plan is approximately $122,000 in FY 2021 and $129,000 in FY 2022. 1% of the total amount paid by the State of Iowa Plan for medical and pharmaceutical expenses.
- Diagnostic Imaging, Insurance · 27 de febrero de 2020
Lo que cambia del Código de Iowa (Iowa Code)
Crea§514C.4A
Cabildeo
2 a favor · 0 en contra · 17 indecisos · Quiénes →
Family tree
Study bill
88th General Assembly
Earlier and later bills are matched by wording or an identical title.
Similar bills
- SF 136 Relating to insurance coverage for diagnostic breast cancer examinations, and including ap…89th General Assembly · In committeeNearly identical
- SF 2164 Relating to insurance coverage for diagnostic breast cancer examinations, and including ap…89th General Assembly · In committeeNearly identical
- HF 874 Relating to insurance coverage for diagnostic breast cancer examinations, and including ap…89th General Assembly · In committeeNearly identical
- HF 71 Relating to insurance coverage for diagnostic breast cancer examinations90th General Assembly · Renumbered as HF 2489Very similar
Matched by wording or an identical title.